Search our Database of Scientific Publications and Authors

I’m looking for a

    528 results match your criteria Familial Benign Pemphigus Hailey-Hailey Disease

    1 OF 11

    Low dose naltrexone: a novel treatment for Hailey-Hailey disease.
    Br J Dermatol 2017 Oct 9. Epub 2017 Oct 9.
    Department of Dermatology, Belfast City Hospital, Belfast, Northern Ireland, UK.
    Hailey-Hailey disease (chronic benign familial pemphigus) is a rare inherited dermatosis typically characterised by erosions at intertriginous sites preceded by minor trauma or stress. We report a case of treatment resistant Hailey-Hailey disease, having failed topical and oral steroids, prophylactic acyclovir and doxycycline, and systemic therapies including dapsone, acitretin and ciclosporin. Low dose naltrexone (LDN) 4. Read More

    Dermoscopic and reflectance confocal microscopic presentation of Hailey-Hailey disease: A case series.
    Skin Res Technol 2017 Aug 7. Epub 2017 Aug 7.
    Department of Dermatology, Hospital de Santa Maria, Lisbon, Portugal.
    Background/purpose: Hailey-Hailey disease is a rare inherited acantholytic skin disorder characterized by heterogeneous clinical presentation. Its differential diagnosis might be wide, including other genodermatoses, inflammatory, and infectious skin diseases. Although histopathology remains as diagnostic gold standard, noninvasive techniques such as dermoscopy and reflectance confocal microscopy may assist clinical examination. Read More

    Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease).
    JAMA Dermatol 2017 Oct;153(10):1015-1017
    Department of Dermatology, Cleveland Clinic Foundation, Cleveland, Ohio.
    Importance: Familial benign pemphigus, or Hailey-Hailey disease (HHD), is a rare and debilitating genetic dermatosis characterized by chronic, recurrent vesicles, erosions, and maceration in flexural areas. Despite the reported therapeutic modalities, such as topical and systemic corticosteroids, systemic immunomodulators, topical and systemic retinoids, and laser, HHD can still be markedly difficult to control.

    Objective: To assess low-dose naltrexone hydrochloride in the treatment of recalcitrant HHD. Read More

    [Treatment of Hailey-Hailey disease with botulinic toxin: A retrospective study of 8 cases].
    Ann Dermatol Venereol 2017 Oct 29;144(10):599-606. Epub 2017 Jun 29.
    Service de dermatologie, hôpital Saint-André, 1, rue Jean-Burguet, 33000 Bordeaux, France. Electronic address:
    Background: Hailey-Hailey disease (HHD) is characterised by episodes of weeping erythematous lesions, particularly in areas subject to friction or maceration. Treatment is complex. The value of botulinum toxin has been demonstrated in several studies and in individual cases. Read More

    Is photodynamic therapy a relevant therapeutic option in refractory benign familial pemphigus (Hailey-Hailey disease)? A series of eight patients.
    J Dermatolog Treat 2017 Apr 2:1-5. Epub 2017 Apr 2.
    a Department of Dermatology and INSERM , University of Montpellier , Montpellier , France.
    Introduction/background: Treatment of benign familial pemphigus or Hailey-Hailey disease (HHD), a rare inherited condition associated with a significant impairment of quality of life, is often challenging and disappointing with frequent relapses and infectious complications. Topical photodynamic therapy (PDT) may offer new perspectives in this difficult setting.

    Material And Methods: Eight patients with long-lasting HHD lesions refractory to multiple treatments were treated on at least one involved site with PDT using methyl-amino levulinate with a standardized protocol of three sessions of irradiation separated by 3-week intervals. Read More

    Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms.
    J Cutan Pathol 2016 Nov 22;43(11):1031-1035. Epub 2016 Aug 22.
    Department of Dermatology, Yale School of Medicine, New Haven, CT, 06520-8059, USA.
    We describe a 65-year-old Caucasian female with well-controlled Hailey-Hailey disease (HHD) who developed acute generalized exanthematous pustulosis (AGEP) with severe systemic symptoms. Despite sparing of the patient's intertriginous skin, histopathologic evidence of HHD was observed in all biopsies, suggestive of a unique koebernization phenomenon of HHD to areas of cutaneous drug eruption. While internal organ involvement is less commonly reported in AGEP, there are an increasing number of patients with signs and symptoms suggestive of an AGEP/drug reaction with eosinophilia and systemic symptoms (DRESS) spectrum of cutaneous drug disorders. Read More

    Interventional treatments for Hailey-Hailey disease.
    J Am Acad Dermatol 2017 Mar 13;76(3):551-558.e3. Epub 2016 Oct 13.
    Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina.
    Hailey-Hailey disease or familial benign chronic pemphigus is a rare blistering dermatosis that is characterized by recurrent erythematous plaques with a predilection for the skin folds. For extensive Hailey-Hailey disease that is recalcitrant to conventional therapy, laser ablation, photodynamic therapy, electron beam radiotherapy, botulinum toxin type A, dermabrasion, glycopyrrolate, and afamelanotide have been reported as useful treatments, but comparative trials are lacking. This review discusses the various treatment modalities for Hailey-Hailey disease and a summary of the evidence for the most recommended treatments. Read More

    Management of familial benign chronic pemphigus.
    Clin Cosmet Investig Dermatol 2016 14;9:281-290. Epub 2016 Sep 14.
    Department of Dermatology and Cutaneous Surgery, University of Miami-Miller School of Medicine, Miami, FL, USA.
    Benign familial chronic pemphigus or Hailey-Hailey disease is caused by an autosomal dominant mutation in the ATP2C1 gene leading to suprabasilar acantholysis. The disease most commonly affects intertriginous areas symmetrically. The chronic nature of the disease and multiple recurrences make the disease bothersome for patients and a treatment challenge for physicians. Read More

    Familial benign pemphigus atypical localization.
    Dermatol Online J 2016 Apr 18;22(4). Epub 2016 Apr 18.
    Hospital Privado de Córdoba.
    We present an atypical case of familial benign pemphigus (Hailey-Hailey disease), which presented as crusted, annular plaques limited to the back without intertriginous involvement. We could not find in the literature another patient with plaques located solely on the back without a prior history of classical disease. Read More

    Glutathione S-transferase ϴ-subunit as a phenotypic suppressor of pmr1Δ strain, the Kluyveromyces lactis model for Hailey-Hailey disease.
    Biochim Biophys Acta 2016 11 11;1863(11):2650-2657. Epub 2016 Aug 11.
    Department of Biology and Biotechnology "C. Darwin", Sapienza University of Rome, Rome, Italy. Electronic address:
    Background: Hailey-Hailey disease (HHD), also known as familial benign chronic pemphigus, is a rare, chronic and recurrent blistering disorder, histologically characterized by suprabasal acantholysis. HHD has been linked to mutations in ATP2C1, the gene encoding the human adenosine triphosphate (ATP)-powered calcium channel pump.

    Methods: In this work, the genetically tractable yeast Kluyveromyces lactis has been used to study the molecular basis of Hailey-Hailey disease. Read More

    A Bullous Flare of a Hyperkeratotic Affair: A Case Report.
    J Cutan Med Surg 2016 Nov 12;20(6):589-591. Epub 2016 Jul 12.
    Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
    Background: Darier's disease is an autosomal dominant genodermatosis typified by hyperkeratotic papules and plaques in a predominately seborrheic distribution. The vesiculo-bullous variant of Darier's disease is rare. Several previously reported cases have demonstrated clinical and microscopic features resembling familial benign chronic pemphigus or Hailey-Hailey disease. Read More

    A novel missense mutation of the ATP2C1 gene in a Chinese patient with papular acantholytic dermatosis of the anogenital area.
    Indian J Dermatol Venereol Leprol 2016 Jul-Aug;82(4):429-31
    Department of Dermatology, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Nanjing, Jiangsu 210042; Department of Dermatology, Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, Jiangsu 210042, China.

    ATP2C1 gene mutations in Hailey-Hailey disease and possible roles of SPCA1 isoforms in membrane trafficking.
    Cell Death Dis 2016 Jun 9;7(6):e2259. Epub 2016 Jun 9.
    Aging Research Center (Ce.S.I.), University 'G. D'Annunzio' of Chieti-Pescara, Chieti 66100, Italy.
    ATP2C1 gene codes for the secretory pathway Ca(2+)/Mn(2+)-ATPase pump type 1 (SPCA1) localizing at the golgi apparatus. Mutations on the human ATP2C1 gene, causing decreased levels of the SPCA1 expression, have been identified as the cause of the Hailey-Hailey disease, a rare skin disorder. In the last few years, several mutations have been described, and here we summarize how they are distributed along the gene and how missense mutations affect protein expression. Read More

    Four novel ATP2C1 mutations in Chinese patients with Hailey-Hailey disease.
    J Dermatol 2016 Oct;43(10):1197-1200
    Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
    Hailey-Hailey disease (HHD) is a kind of autosomal dominant dermatosis. The ATP2C1 gene has been identified as the pathogenic gene of HHD since 2000. In this study, direct DNA sequencing was used to identify ATP2C1 gene mutations in four Chinese families and two sporadic cases with HHD. Read More

    Two novel ATP2C1 mutations in patients with Hailey-Hailey disease and a literature review of sequence variants reported in the Chinese population.
    Genet Mol Res 2015 Dec 29;14(4):19349-59. Epub 2015 Dec 29.
    Department of Phototherapy, Shanghai Skin Disease Hospital, Shanghai, China.
    Hailey-Hailey disease (HHD) is an autosomal dominant disorder in which the ATP2C1 gene has been implicated. Many mutations of this gene have been detected in HHD patients. To analyze such mutations in HHD and summarize all those identified in Chinese patients with this disease, we examined four familial and two sporadic cases and searched for case reports and papers by using the Chinese Biological Medicine Database and PubMed. Read More

    Efficacy of magnesium chloride in the treatment of Hailey-Hailey disease: some further considerations.
    Int J Dermatol 2016 Mar 31;55(3):e170-1. Epub 2015 Oct 31.
    Department of Morphology, Surgery and Experimental Medicine, Section of General Pathology, Interdisciplinary Center for the Study of Inflammation (ICSI), Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.

    Carbon dioxide laser treatment for Hailey-Hailey disease: a retrospective chart review with patient-reported outcomes.
    Int J Dermatol 2015 Nov 4;54(11):1309-14. Epub 2015 Sep 4.
    Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
    Background: Hailey-Hailey disease (HHD) is an autosomal dominant genodermatosis that leads to skin breakdown and blister formation, usually in intertriginous areas. Laser ablation is a known surgical treatment for HHD.

    Objectives: We report outcomes in a series of patients with HHD treated with carbon dioxide (CO2 ) laser ablation. Read More

    Hailey-Hailey disease: A fold (intertriginous) dermatosis.
    Clin Dermatol 2015 Jul-Aug;33(4):452-5. Epub 2015 Apr 8.
    Department of Dermatology, Cerrahpaşa Medical Faculty, Istanbul University, Fatih, Istanbul 34098, Turkey.
    Hailey-Hailey disease, also called benign familial pemphigus, is a late-onset blistering disorder that affects the flexures. There are typically painful erosions and cracks in affected areas. Lesions generally begin between 20 and 40 years of age. Read More

    A recurrent melanocytic nevus phenomenon in the setting of Hailey-Hailey disease.
    J Cutan Pathol 2015 Aug 26;42(8):574-7. Epub 2015 May 26.
    Department of Dermatology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
    Atypical acquired melanocytic nevi in patients with epidermolysis bullosa (EB) have been referred to as EB nevi and are considered to be a type of recurrent nevus with atypical but distinctive histopathologic findings. Herein, we describe an atypical nevus in a patient with Hailey-Hailey disease with different histopathologic findings from EB nevi because of presumably different pathogenesis. It is important to be aware that the recurrent nevi phenomenon can be seen in acantholytic conditions as well as blistering disorders, given these lesions may clinically resemble melanoma. Read More

    A family with atypical Hailey Hailey disease--is there more to the underlying genetics than ATP2C1?
    PLoS One 2015 2;10(4):e0121253. Epub 2015 Apr 2.
    Department of Dermatology, Allergology and Venerology, University of Luebeck, Luebeck, Germany.
    The autosomal dominant Hailey Hailey disease (HHD) is caused by mutations in the ATP2C1 gene encoding for human secretory pathway Ca2+/Mn2+ ATPase protein (hSPCA1) in the Golgi apparatus. Clinically, HHD presents with erosions and hyperkeratosis predominantly in the intertrigines. Here we report an exome next generation sequencing (NGS) based analysis of ATPase genes in a Greek family with 3 HHD patients presenting with clinically atypical lesions mainly localized on the neck and shoulders. Read More

    Remission of refractory benign familial chronic pemphigus (hailey-hailey disease) with the addition of systemic cyclosporine.
    J Cutan Med Surg 2015 Mar-Apr;19(2):163-6. Epub 2015 Mar 5.
    Department of Dermatology, Tufts Medical Center, Boston, MA, and private practice, Chelmsford, MA.
    Background: Benign chronic familial pemphigus (BFCP) is an autosomal dominant dermatosis characterized by flares of painful and often debilitating blistering lesions in high friction areas of the body such as the groin, axillae, lateral neck, and intergluteal cleft. Limited knowledge of its pathophysiology has made treatment of BFCP a considerable challenge and efficacy with current first line therapies, topical corticosteroids and antibiotics, is variable.

    Case Report: We present a case of this disease in a 52 year old woman that has responded dramatically to the addition of oral cyclosporine to her existing regimen of oral acitretin, with significant improvement of skin lesions, mobility, and quality of life. Read More

    Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients.
    Dermatol Ther 2015 May-Jun;28(3):158-65. Epub 2015 Mar 3.
    Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
    Tumor necrosis factor-alpha (TNF)-alpha inhibitors are licensed for patients with severe refractory psoriasis and psoriatic arthritis. However, TNF-alpha inhibitors have also been used off-label for various recalcitrant mucocutaneous diseases. This study aimed to evaluate the efficacy and safety of TNF-alpha inhibitors used for off-label dermatological indications. Read More

    Identification of several mutations in ATP2C1 in Lebanese families: insight into the pathogenesis of Hailey-Hailey disease.
    PLoS One 2015 6;10(2):e0115530. Epub 2015 Feb 6.
    Department of Dermatology, American University of Beirut, Beirut, Lebanon; Department of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon; Department of Dermatology, Columbia University, New York, New York, United States of America.
    Background: Hailey-Hailey disease (HHD) is an inherited blistering dermatosis characterized by recurrent erosions and erythematous plaques that generally manifest in intertriginous areas. Genetically, HHD is an autosomal dominant disease, resulting from heterozygous mutations in ATP2C1, which encodes a Ca2+/Mn2+ATPase. In this study, we aimed at identifying and analyzing mutations in five patients from unrelated families diagnosed with HHD and study the underlying molecular pathogenesis. Read More

    Successful botulinum toxin (onabotulinumtoxinA) treatment of Hailey-Hailey disease.
    J Drugs Dermatol 2015 Jan;14(1):68-70
    Hailey-Hailey disease is a genetic disorder that affects flexural skin with scale, blisters, and maceration. Botulinum toxins have been previously used to treat Hailey-Hailey disease. Here, we present a patient who underwent one treatment of onabotulinumtoxinA and achieved excellent improvement that was sustained for three months post initial treatment. Read More

    Hailey-Hailey disease and review of management.
    J Drugs Dermatol 2014 Oct;13(10):1254-7
    Importance: Hailey-Hailey disease, or familial benign chronic pemphigus, is a rare genodermatosis that can be challenging for both patients and dermatologists as the disease can significantly impact patients' quality of life and is often difficult to control. In recalcitrant cases, multiple treatment modalities are often needed to obtain benefit. Unfortunately, most of the available evidence pertaining to treatment is scattered across case reports and retrospective analyses. Read More

    Hailey-Hailey disease improved by fractional CO2 laser.
    J Cosmet Laser Ther 2015 13;17(4):213-5. Epub 2015 Feb 13.
    Department of Dermatology, Hospital Central Dr. Ignacio Morones Prieto, Universidad Autónoma de San Luis Potosí , San Luis Potosi , México.
    Hailey-Hailey disease (HHD), also known as benign familial pemphigus, is an autosomal dominant skin condition that affects the adhesion of epidermal keratinocytes. Although the initial manifestation of flaccid vesicles on erythematous or normal skin in flexure sites frequently goes unnoticed, large, macerated, exudative plaques of superficial erosions with crusting are observed at the time of diagnosis. There is no specific treatment for HHD, and most cases are symptomatically supported. Read More

    Benign familial pemphigus (Hailey-Hailey disease).
    Dermatol Online J 2015 Dec 16;21(12). Epub 2015 Dec 16.
    New York University School of Medicine.
    A 56-year-old man presented with a 15-year history of scaly red plaques on the trunk and axillae. Skin biopsy was consistent with Hailey-Hailey disease. His condition was refractory to multiple therapies, which included topical and oral antibiotics and topical, intralesional, and oral glucocorticoids. Read More

    Hailey-Hailey disease exacerbated by multiple pregnancies: case report and review of the literature.
    Dermatol Online J 2014 Oct 15;20(10). Epub 2014 Oct 15.
    University of Texas health Science Center at Houston.
    Hailey-Hailey disease is a rare chronic skin disorder that is inherited in an autosomal dominant manner. The disease is characterized by development of vesicles and bullae typically in the intertriginous areas. On histology, there is widespread intraepidermal acantholysis causing the "dilapidated brick-wall" appearance. Read More

    Efficacy of magnesium chloride in the treatment of Hailey-Hailey disease: from serendipity to evidence of its effect on intracellular Ca(2+) homeostasis.
    Int J Dermatol 2015 28;54(5):543-8. Epub 2014 Nov 28.
    Department of Medical Sciences, Section of Dermatology, University of Ferrara, Ferrara, Italy.
    Background: Hailey-Hailey disease (HHD), also known as familial benign chronic pemphigus, is a rare autosomal dominant inherited intraepidermal blistering genodermatosis. Mutations in the ATP2C1 gene encoding for the Golgi secretory pathway Ca(2+) /Mn(2+) -ATPasi protein 1 (SPCA1) affect the processing of desmosomal components and the epidermal suprabasal cell-cell adhesion by deregulating the keratinocyte cytosolic Ca(2+) concentration. We report the unexpected, dramatic, and persistent clinical improvement of the skin lesions of a patient affected with longstanding HHD with daily intake of a solution containing magnesium chloride hexahydrate (MgCl2 ). Read More

    1 OF 11